BackEntrada Therapeutics Overview

Entrada Therapeutics Minority Interest

Track Entrada Therapeutics's minority interest ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer average

Loading

Entrada Therapeutics Minority Interest History

Loading

Entrada Therapeutics vs. peers: Minority Interest Comparison

Loading

Entrada Therapeutics Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Entrada Therapeutics (TRDA) FAQ

As of the most recent data (March 2026), TRDA shows a minority interest of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TRDA's minority interest is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Entrada Therapeutics is outperforming or lagging.

Tracking TRDA's minority interest over time shows whether Entrada Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Entrada Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $0) with ownership activity and broader fundamentals.